Operating Income - Obio Technology Shanghai Corp Ltd (SSE:688238) - Alpha Spread
O

Obio Technology Shanghai Corp Ltd
SSE:688238

Watchlist Manager
Obio Technology Shanghai Corp Ltd
SSE:688238
Watchlist
Price: 3.88 CNY -4.2%
Market Cap: 2.5B CNY
Have any thoughts about
Obio Technology Shanghai Corp Ltd?
Write Note

Obio Technology Shanghai Corp Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Obio Technology Shanghai Corp Ltd
Operating Income Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
O
Obio Technology Shanghai Corp Ltd
SSE:688238
Operating Income
-ÂĄ170.6m
CAGR 3-Years
N/A
CAGR 5-Years
-39%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Operating Income
ÂĄ10.6B
CAGR 3-Years
37%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Operating Income
ÂĄ1.6B
CAGR 3-Years
5%
CAGR 5-Years
25%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Operating Income
ÂĄ3.7B
CAGR 3-Years
9%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Operating Income
ÂĄ1.5B
CAGR 3-Years
13%
CAGR 5-Years
20%
CAGR 10-Years
30%
Genscript Biotech Corp
HKEX:1548
Operating Income
-$395m
CAGR 3-Years
-12%
CAGR 5-Years
-51%
CAGR 10-Years
N/A

See Also

What is Obio Technology Shanghai Corp Ltd's Operating Income?
Operating Income
-170.6m CNY

Based on the financial report for Dec 31, 2023, Obio Technology Shanghai Corp Ltd's Operating Income amounts to -170.6m CNY.

What is Obio Technology Shanghai Corp Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-39%

Back to Top